{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:36:11Z","timestamp":1792697771391,"version":"4.5.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Stroke is a neurological disease and a leading cause of mortality worldwide. Strokes mainly consist of two types: hemorrhage and ischemia. Stroke patients are being administered multiple drug therapy and are at risk of drug-related problems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To estimate drug-related problems (DRPs) and clinical end outcomes in hospitalized stroke patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Current study was a multicenter, cross-sectional prospective observational study including 250 stroke patients admitted to tertiary care hospitals in Karachi, Pakistan. The study included all clinical subtypes of stroke patients i.e. Stroke, Ischemic stroke, Hemorrhagic stroke, CVA, and TIA. Associations among patient-clinical end outcomes and drug therapy-related variables like DRPs, mortality, and morbidity rates were estimated using Pearson\u2019s chi-squared test. Statistical analysis was done by using SPSS software, version 25.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 250 patients participated in this study suffering from different clinical subtypes of stroke i.e. Ischemic stroke, hemorrhagic stroke, TIA, and CVA, including 46% male and 54% female patients. The majority of patients\u2019 stay at the hospital was between 1\u201310 days. The overall mortality rate in stroke patients was 51%. HAIs were observed in 70% of patients, HAIs faced by patients were SAP, CAP, UTI, sepsis, and VAP. Drugs were assessed according to NEML i.e. access group antibiotics, watch group antibiotics, reserve group antibiotics, statins, antiepileptics, and proton pump inhibitors. Majorly ceftriaxone was administered to 79% of patients, piperacillin-tazobactam to 52%, and cefixime to 48%, whereas meropenem was administered to 42% of patients along with vancomycin to 39% of total patients. A high mortality rate was observed in the case of\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      and\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      i.e. 78% and in the case of\n                      <jats:italic>streptococcus pneumoniae<\/jats:italic>\n                      61% mortality rate was observed. Due to the presence of DRPs and various other clinical factors like comorbidities, DDIs, HAIs, administration of potentially nephrotoxic drugs, and administration of antibiotics without having CST, hospitalized stroke patients faced many problems.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec005\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study helped determine DRPs along with various clinical factors affecting the clinical end outcomes of patients suffering from any clinical subtype of stroke. Due to the enhancement in the evidence of the incidence of DRPs in tertiary care hospitals, pharmacist-led drug therapy review by interfering with doctors and other medical professionals at the patient bed site is needed and should be done to avoid any negative end outcomes and serious issues related to DRPs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0295208","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T14:08:23Z","timestamp":1704204503000},"page":"e0295208","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["A prospective observational study of estimating drug related problems and clinical outcomes in subtypes of stroke patients"],"prefix":"10.1371","volume":"19","author":[{"given":"Muhammad","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3639-0026","authenticated-orcid":true,"given":"Muhammad Harris","family":"Shoaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shagufta","family":"Nesar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabiha","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saira","family":"Shahnaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoaib","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quratulain","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javaria","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"issue":"3","key":"pone.0295208.ref001","first-page":"235","article-title":"Effect of urgent treatment for transient ischaemic attack and minor stroke on disability and hospital costs (EXPRESS study): a prospective population-based sequential comparison.","volume":"8","author":"R Luengo-Fernandez","year":"2009"},{"key":"pone.0295208.ref002","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9781316095805","author":"LR Caplan","year":"2016","journal-title":"Caplan\u2019s stroke: Cambridge University Press"},{"issue":"20","key":"pone.0295208.ref003","first-page":"7609","article-title":"Xiao ZJIJoMS. Pathophysiology and Treatment of Stroke","volume":"21","author":"D Kuriakose","year":"2020","journal-title":"Present Status and Future Perspectives"},{"issue":"12","key":"pone.0295208.ref004","first-page":"1029","volume":"20","author":"YL Wang","year":"2014","journal-title":"Recurrent stroke was associated with poor quality of life in patients with transient ischemic attack or minor stroke: finding from the CHANCE trial"},{"issue":"1","key":"pone.0295208.ref005","first-page":"92","volume":"51","author":"E Lendraitien\u0117","year":"2017","journal-title":"Balance evaluation techniques and physical therapy in post-stroke patients: A literature review"},{"issue":"10","key":"pone.0295208.ref006","first-page":"915","article-title":"Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes.","volume":"7","author":"MJ Reeves","year":"2008"},{"issue":"184","key":"pone.0295208.ref007","first-page":"2167","article-title":"Pharmacotherapeutical Study of Stroke Patients: A Hospital Based Survey.","volume":"5","author":"S Ullah","year":"2015","journal-title":"Primary Health Care"},{"issue":"1","key":"pone.0295208.ref008","volume":"52","author":"F Sharif","year":"2019","journal-title":"Prevalence of risk factors associated with stroke"},{"issue":"4","key":"pone.0295208.ref009","first-page":"1237","article-title":"Liao YJIJoCP. Characteristics of drug-related problems among hospitalized ischemic stroke patients","volume":"42","author":"Q Chen","year":"2020","journal-title":"China"},{"issue":"3","key":"pone.0295208.ref010","first-page":"245","volume":"13","author":"A Stephenson","year":"2018","journal-title":"An exploration of physiotherapists\u2019 experiences of robotic therapy in upper limb rehabilitation within a stroke rehabilitation centre"},{"key":"pone.0295208.ref011","first-page":"828","volume":"34","author":"C Hohmann","year":"2012","journal-title":"Drug-related problems in patients with ischemic stroke in hospital"},{"issue":"3","key":"pone.0295208.ref012","volume":"12","author":"MH Rashid","year":"2020","journal-title":"Role of prophylactic antibiotics in critical care of stroke patients-a preventive approach to post-stroke infections?"},{"issue":"5\u20136","key":"pone.0295208.ref013","first-page":"506","volume":"42","author":"WF Westendorp","year":"2016","journal-title":"Pre-stroke use of beta-blockers does not lower post-stroke infection rate: an exploratory analysis of the preventive antibiotics in stroke study"},{"issue":"9","key":"pone.0295208.ref014","first-page":"913","volume":"13","author":"J-D Vermeij","year":"2018","journal-title":"Nederkoorn PJJIJoS. Post-stroke infections and preventive antibiotics in stroke: update of clinical evidence"},{"issue":"3","key":"pone.0295208.ref015","first-page":"141","volume":"14","author":"DP Thammisetty","year":"2021","journal-title":"Drug-related problems and its prescribing indicators in stroke patients: a prospective observational study"},{"key":"pone.0295208.ref016","volume":"14","author":"6","year":"2022","journal-title":"Prevalence of Dyslipidemia in Ischemic Stroke Patients: A Single-Center Prospective Study From Pakistan"},{"issue":"1","key":"pone.0295208.ref017","article-title":"Stroke and its relationship to risk factors","volume":"7","author":"MA Marwat","year":"2004","journal-title":"Gomal Journal of Medical Sciences"},{"key":"pone.0295208.ref018","author":"CT Kim","year":"2012","journal-title":"Stroke rehabilitation: INTECH Open Access Publisher"},{"issue":"8","key":"pone.0295208.ref019","first-page":"869","volume":"56","author":"KA Parsels","year":"2022","journal-title":"Hospital discharge: an opportune time for antimicrobial stewardship."},{"issue":"Supplement_3","key":"pone.0295208.ref020","first-page":"S192","volume":"69","author":"J Baloh","year":"2019","journal-title":"Healthcare workers\u2019 strategies for doffing personal protective equipment"},{"issue":"2","key":"pone.0295208.ref021","volume":"8","author":"YA Alomi","year":"2022","journal-title":"Pharmacy Infection Control: Basic Hygiene for Pharmacy Staff"},{"key":"pone.0295208.ref022","first-page":"12","article-title":"Pharmaceutical care issues in patients with atrial fibrillation receiving thromboprophylaxis.","volume":"5","author":"MJ Farrukh","year":"2014","journal-title":"Am J Pharmacol Sci."},{"issue":"1","key":"pone.0295208.ref023","first-page":"31","article-title":"Prediction of creatinine clearance from serum creatinine.","volume":"16","author":"DW Cockcroft","year":"1976"},{"key":"pone.0295208.ref024","author":"CL Preston","year":"2016","journal-title":"Stockley\u2019s drug interactions: pharmaceutical Press London"},{"key":"pone.0295208.ref025","author":"K Baxter","year":"2010","journal-title":"Stockley\u2019s drug interactions: Pharmaceutical Press London"},{"issue":"1","key":"pone.0295208.ref026","first-page":"144","volume":"34","author":"R Farooqui","year":"2018","journal-title":"Potential drug-drug interactions among patients prescriptions collected from medicine out-patient setting."},{"key":"pone.0295208.ref027","author":"H Sohail","year":"2021","journal-title":"FLOUROQUINOLONES PRESCRIBING IN PRIVATE AND GOVERNMENT HOSPITALS IN KARACHI, PAKISTAN."},{"issue":"3","key":"pone.0295208.ref028","first-page":"321","volume":"66","author":"M Glim\u00e5ker","year":"2018","journal-title":"Lumbar puncture performed promptly or after neuroimaging in acute bacterial meningitis in adults: a prospective national cohort study evaluating different guidelines."},{"key":"pone.0295208.ref029","first-page":"493","author":"M Ali","year":"2019","journal-title":"Rational use of antibiotics in an intensive care unit: a retrospective study of the impact on clinical outcomes and mortality rate"},{"key":"pone.0295208.ref030","author":"WH Organization","year":"2019","journal-title":"The selection and use of essential medicines: report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2019 (including the 21st WHO Model List of Essential Medicines and the 7th WHO Model List of Essential Medicines for Children)."},{"key":"pone.0295208.ref031","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00228-019-02796-w","article-title":"Comparison of drug-related problem risk assessment tools for older adults: a systematic review","volume":"76","author":"E Puumalainen","year":"2020","journal-title":"European Journal of Clinical Pharmacology"},{"key":"pone.0295208.ref032","first-page":"155","article-title":"Identification of drug-related problems of elderly patients discharged from hospital.","author":"A Ahmad","year":"2014","journal-title":"Patient preference and adherence"},{"issue":"17","key":"pone.0295208.ref033","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1001\/archinternmed.2012.2816","article-title":"Effect of a pharmacist medication review in elderly patients discharged from the hospital","volume":"172","author":"A Ahmad","year":"2012","journal-title":"Archives of internal medicine"},{"issue":"6","key":"pone.0295208.ref034","first-page":"378","volume":"96","author":"L Roth","year":"2018","journal-title":"Monographs for medicines on WHO\u2019s model list of essential medicines."},{"issue":"7","key":"pone.0295208.ref035","first-page":"e0253880","volume":"16","author":"S Rafi","year":"2021","journal-title":"Availability of essential medicines in Pakistan\u2014A comprehensive document analysis."},{"issue":"3","key":"pone.0295208.ref036","first-page":"30","volume":"13","author":"MI Khan","year":"2019","journal-title":"The epidemiology of stroke in a developing country (Pakistan)."},{"issue":"3","key":"pone.0295208.ref037","first-page":"297","article-title":"Impact of stroke-associated infection on long-term survival: a cohort study.","volume":"84","author":"J Kwan","year":"2013"},{"issue":"10","key":"pone.0295208.ref038","first-page":"2399","volume":"25","author":"JF Colbert","year":"2016","journal-title":"Sex-related differences in the risk of hospital-acquired sepsis and pneumonia post acute ischemic stroke"},{"issue":"4","key":"pone.0295208.ref039","first-page":"424","volume":"22","author":"N Popovi\u0107","year":"2013","journal-title":"The frequency of poststroke infections and their impact on early stroke outcome"},{"issue":"2","key":"pone.0295208.ref040","first-page":"108","volume":"113","author":"U Fischer","year":"2006","journal-title":"Impact of comorbidity on ischemic stroke outcome"},{"key":"pone.0295208.ref041","first-page":"248","volume":"7","author":"A Ergul","year":"2016","journal-title":"Impact of comorbidities on acute injury and recovery in preclinical stroke research: focus on hypertension and diabetes"},{"issue":"9","key":"pone.0295208.ref042","first-page":"e254","volume":"51","author":"G Ntaios","year":"2020","journal-title":"Characteristics and outcomes in patients with COVID-19 and acute ischemic stroke: the global COVID-19 stroke registry"},{"issue":"3","key":"pone.0295208.ref043","first-page":"905","volume":"52","author":"AI Qureshi","year":"2021","journal-title":"Acute ischemic stroke and COVID-19: an analysis of 27 676 patients."},{"issue":"5","key":"pone.0295208.ref044","first-page":"589","volume":"15","author":"JS Al-Maqbali","year":"2022","journal-title":"Vancomycin Therapeutic Drug Monitoring (TDM) and Its Association with Clinical Outcomes: A Retrospective Cohort."},{"key":"pone.0295208.ref045","first-page":"2018","author":"ESJSr Donkor","year":"2018","journal-title":"treatment. Stroke in the century: a snapshot of the burden, epidemiology, and quality of life"},{"issue":"7","key":"pone.0295208.ref046","first-page":"1602","volume":"49","author":"AK Kishore","year":"2018","journal-title":"Microbiological etiologies of pneumonia complicating stroke: a systematic review"},{"key":"pone.0295208.ref047","first-page":"2050312121989625","volume":"9","author":"F Bekele","year":"2021","journal-title":"Sori JJSom. Drug-related problems among patients with infectious disease admitted to medical wards of Wollega University Referral Hospital: Prospective observational study."},{"key":"pone.0295208.ref048","first-page":"880","volume":"41","author":"K Semcharoen","year":"2019","journal-title":"Characteristic of drug-related problems and pharmacists\u2019 interventions in a stroke unit in Thailand."},{"issue":"3","key":"pone.0295208.ref049","first-page":"222","volume":"5","author":"VS Kanagala","year":"2016","journal-title":"A study of medication-related problems in stroke patients: A need for pharmaceutical care"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0295208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T14:08:48Z","timestamp":1704204528000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0295208"}},"subtitle":[],"editor":[{"given":"Gul","family":"Ambreen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0295208","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]}}}